Evidence map›Paper›PMID 30367148›Full record

ArticleScientific reports2018

Solid-phase enzyme catalysis of DNA end repair and 3' A-tailing reduces GC-bias in next-generation sequencing of human genomic DNA.

Aihua Zhang, Shaohua Li, Lynne Apone, Xiaoli Sun, Lixin Chen, Laurence M Ettwiller, Bradley W Langhorst, Christopher J Noren, Ming-Qun Xu

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aihua ZhangNew England Biolabs, Inc., 240 County Road, Ipswich, MA, 01938, USA.
Shaohua LiNew England Biolabs, Inc., 240 County Road, Ipswich, MA, 01938, USA.ORCID http://orcid.org/0000-0001-7115-5809
Lynne AponeNew England Biolabs, Inc., 240 County Road, Ipswich, MA, 01938, USA.
Xiaoli SunNew England Biolabs, Inc., 240 County Road, Ipswich, MA, 01938, USA.
Lixin ChenNew England Biolabs, Inc., 240 County Road, Ipswich, MA, 01938, USA.
Laurence M EttwillerNew England Biolabs, Inc., 240 County Road, Ipswich, MA, 01938, USA.ORCID http://orcid.org/0000-0002-3957-6539
Bradley W LanghorstNew England Biolabs, Inc., 240 County Road, Ipswich, MA, 01938, USA.
Christopher J NorenNew England Biolabs, Inc., 240 County Road, Ipswich, MA, 01938, USA.
Ming-Qun XuNew England Biolabs, Inc., 240 County Road, Ipswich, MA, 01938, USA. xum@neb.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of next-generation sequencing (NGS) has been instrumental in advancing biological research and clinical diagnostics. To fully utilize the power of NGS, complete, uniform coverage of the entire genome is required. In this study, we identified the primary sources of bias observed in sequence coverage across AT-rich regions of the human genome with existing amplification-free DNA library preparation methods. We have found evidence that a major source of bias is the inefficient processing of AT-rich DNA in end repair and 3' A-tailing, causing under-representation of extremely AT-rich regions. We have employed immobilized DNA modifying enzymes to catalyze end repair and 3' A-tailing reactions, to notably reduce the GC bias observed with existing library construction methods.

Indexed as

DNA RepairGenome, HumanBase CompositionDNADNA Repair EnzymesEnzymes, ImmobilizedGene LibraryHigh-Throughput Nucleotide SequencingHumansSequence Analysis, DNATemperatureDNADNA Repair EnzymesEnzymes, Immobilized

Identifiers

PMID30367148
PMCPMC6203771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.